Drug recall
Diltia XT Capsules (diltiazem HCl extended-release capsules, USP) Once-A-Day Dosage, 240 mg, 100 count…
FDA recall event 28474 · Class II · Andrx Pharmaceuticals, Inc.
Key facts
| Event ID | 28474 |
|---|---|
| Recall numbers | D-124-4 |
| Recalling firm | Andrx Pharmaceuticals, Inc. |
| Product type | Drugs |
| Products | Diltia XT Capsules (diltiazem HCl extended-release capsules, USP) Once-A-Day Dosage, 240 mg, 100 count bottles, Rx Only, Manufactured by: Andrx Pharmaceuticals, Inc., Fort Lauderdale, Fl 33314, NDC… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Mislabeling: The recalled product lot was labeled with the incorrect expiration date of November 2004 rather than actual expiration of November 2003. |
| Initiation date | Dec 19, 2003 |
| Termination date | May 3, 2012 |
| City | Fort Lauderdale |
| State | FL |
| Country | United States |
| FEI number | 3003194604 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports